GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $716,000 | -3.6% | 18,726 | +1.3% | 0.33% | -0.3% |
Q3 2018 | $743,000 | -1.8% | 18,490 | -1.5% | 0.34% | +3.7% |
Q2 2018 | $757,000 | -5.5% | 18,781 | +132.1% | 0.32% | -13.6% |
Q1 2018 | $801,000 | +8.7% | 8,093 | -61.1% | 0.37% | +7.5% |
Q4 2017 | $737,000 | -13.9% | 20,791 | -1.4% | 0.35% | -15.9% |
Q3 2017 | $856,000 | -3.3% | 21,081 | +2.8% | 0.41% | -5.5% |
Q2 2017 | $885,000 | +1.0% | 20,514 | -1.3% | 0.44% | +2.6% |
Q1 2017 | $876,000 | +10.1% | 20,786 | +0.6% | 0.43% | +2.6% |
Q4 2016 | $796,000 | -38.4% | 20,666 | -31.0% | 0.42% | -40.1% |
Q3 2016 | $1,292,000 | -0.4% | 29,949 | +0.1% | 0.69% | -8.2% |
Q2 2016 | $1,297,000 | +6.4% | 29,920 | -0.4% | 0.76% | +1.1% |
Q1 2016 | $1,219,000 | +4.3% | 30,051 | +3.7% | 0.75% | +0.5% |
Q4 2015 | $1,169,000 | +30.2% | 28,979 | +24.1% | 0.74% | +23.4% |
Q3 2015 | $898,000 | +5.8% | 23,353 | +14.6% | 0.60% | +23.1% |
Q2 2015 | $849,000 | -3.6% | 20,386 | +6.8% | 0.49% | -4.5% |
Q1 2015 | $881,000 | – | 19,093 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |